Atlas FDA

PD-L1 IHC 28-8 pharmDx

FDA premarket approval P150025/S016 · decided 2025-02-28

Approval details

PMA number
P150025
Supplement
S016
Supplement type
Special (Immediate Track)
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
PD-L1 IHC 28-8 pharmDx
Applicant
Agilent Technologies, Inc.
Date received
2025-01-31
Decision date
2025-02-28
Days to decision
28 days
Decision code
APPR
Advisory committee
Pathology
Expedited review
No
Location
Santa Clara, CA
Statement
Approval for additional quality control tests to raw materials and intermediates that to enhance safety of the finished devices without impacting effectiveness.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GenetiSure Dx Postnatal Assay (K163367)Agilent Technologies, Inc.2017-08-11
MODIFICATION TO DEVICE LINK SYSTEM, MODEL M2376A (K012094)Agilent Technologies, Inc.2001-07-20
AGILENT M2636B TELEMON B MONITOR (TELEMON B) (K011824)Agilent Technologies, Inc.2001-07-02
HEARTSTREAM XL DEFIBIBRILLATOR/MONITOR, MODEL M4735A, HEARTSTREAM XLT DEFIBRILLATOR/MONITOR.MODEL M2500B (K010634)Agilent Technologies, Inc.2001-06-11
M2376A DEVICELINK SYSTEM, MODEL M2376A (K011578)Agilent Technologies, Inc.2001-06-08
HEARTSTREAM ATTENUATED DEFIBRILLATION PADS, MODEL M3870A (K003819)Agilent Technologies, Inc.2001-05-02
AGILENT INFORMATION CENTER SOFTWARE FOR M3150,M3151,M3153 AND M3154 (K011093)Agilent Technologies, Inc.2001-05-01
M2376A DEVICELINK SYSTEM (K010453)Agilent Technologies, Inc.2001-03-02